Plasma exchange is a well established immunomodulatory therapy which rapidly removes disease mediators and circulating immune complexes to relieve GBS and MG symptoms. (Saperstein and Barohn, 2004) Physicians can quantify and measure known disease mediators before plasma exchange as well as after in order to inform the next phase of treatment providing immediate objective results. (Derksen, 1984)
Reeves HM, Winters JL. The mechanisms of action of plasma exchange. Br J Haematol. 2014;164(3);342-351.
See how one physician uses the Spectra Optia system’s plasma exchange therapy using peripheral access on an outpatient basis.
Possible patient reactions
Reactions to transfused blood products can include1
Restricted to prescription use only
1AABB (ed.), et al., Circular of Information for the Use of Human Blood and Blood Components. 2006, tenth edition, Council of Europe Publishing, Seattle, WA.
2American Society for Apheresis. Guidelines for therapeutic apheresis clinical privileges. J Clin Apher. 2007;22(3):181-182.
International Content. Approved labeling, indications and instructions may vary by country. Reference the Instructions for Use labeling for a complete listing of indications, warnings and precautions.
Products available in select markets.